Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma

BMC Clinical Pathology

Volumn 14, Issue 1, 2014, Pages

  Wirsing, Anna M ^a   Rikardsen, Oddveig G ^a,b   Steigen, Sonja E ^a,b   Uhlin Hansen, Lars ^a,b   Hadler Olsen, Elin ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

B cell; Follicular dendritic cell; Germinal centre; High endothelial venule; Oral squamous cell carcinoma; Prognostic factor; Tertiary lymphoid structure

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CELL AGGREGATION; CHILD; CONTROLLED STUDY; FEMALE; FOLLICULAR DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LYMPHOID TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; NEWBORN; OUTCOME ASSESSMENT; T LYMPHOCYTE; TERTIARY LYMPHOID STRUCTURE;

EID: 84906924648     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-14-38     Document Type: Article

References (32)

1. Barnes L, Pathology And Genetics Of Head And Neck Tumours Lyon: IARC Press vol. 9 2005
2. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT, Head Neck 2002 24 2 165 180
3. Oral squamous cell carcinoma: Review of prognostic and predictive factors. Massano J, Regateiro FS, Januário G, Ferreira A, Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 2006 102 1 67 76
4. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Woolgar JA, Oral Oncol 2006 42 3 229 239
5. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Shah NG, Trivedi TI, Tankshali RA, Goswami JV, Jetly DH, Shukla SN, Shah PM, Verma RJ, Head Neck 2009 31 12 1544 1556
6. The immune contexture in human tumours: impact on clinical outcome. Fridman WH, Pagès F, Sautès-Fridman C, Galon J, Nat Rev Cancer 2012 12 4 298 306
7. The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities. Freiser ME, Serafini P, Weed DT, Immunol Res 2013 57 1-3 52 69
8. Organogenesis of lymphoid tissues. Mebius RE, Nat Rev Immunol 2003 3 4 292 303
9. Lymphoid organ development: from ontogeny to neogenesis. Drayton DL, Liao S, Mounzer RH, Ruddle NH, Nat Immunol 2006 7 4 344 353
10. Tumor high endothelial venules (HEVs) predict lymphocyte infiltration and favorable prognosis in breast cancer. Martinet L, Garrido I, Girard J-P, OncoImmunol 2012 1 5 61 60
11. Lymphoid neogenesis in chronic inflammatory diseases. Aloisi F, Pujol-Borrell R, Nat Rev Immunol 2006 6 3 205 217
12. Follicular dendritic cells, conduits, lymphatic vessels, and high endothelial venules in tertiary lymphoid organs: parallels with lymph node stroma. Stranford S, Ruddle NH, Front Immunol 2012 3 rticle 350
13. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Coppola D, Nebozhyn M, Khalil F, Dai H, Yeatman T, Loboda A, Mule JJ, Am J Pathol 2011 179 1 37 45
14. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. Dieu-Nosjean MC, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, Rabbe N, Laurans L, Tartour E, de Chaisemartin L, Lebecque S, Fridman WH, Cadranel J, J Clin Oncol 2008 26 27 4410 4417
15. Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin. Remark R, Alifano M, Cremer I, Lupo A, Dieu-Nosjean MC, Riquet M, Crozet L, Ouakrim H, Goc J, Cazes A, Fléjou JF, Gibault L, Verkarre V, Régnard JF, Pagès ON, Oudard S, Mlecnik B, Sautès-Fridmaan C, Fridman WH, Damotte D, Clin Cancer Res 2013 19 15 4079 4091
16. CD20+ B cells: the other tumor-infiltrating lymphocytes. Nelson BH, J Immunol 2010 185 9 4977 4982
17. Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas. Nzula S, Going JJ, Stott DI, Cancer Res 2003 63 12 3275 3280
18. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Ogino S, Nosho K, Irahara N, Meyerhardt JA, Baba Y, Shima K, Glickman JN, Ferrone CR, Mino-Kenudson M, Tanaka N, Dranaoff G, Giovannucci EL, Fuchs CS, Clin Cancer Res 2009 15 20 6412 6420
19. Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers. Di Caro G, Bergomas F, Grizzi F, Doni A, Bianchi P, Malesci A, Laghi L, Allavena P, Mantovani A, Marchesi F, Clin Cancer Res 2014 20 8 2147 2158
20. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Goc J, Germain C, Vo-Bourgais TK, Lupo A, Klein C, Knockaert S, de Chaisemartin L, Ouakrim H, Becht E, Alifano M, Validire P, Remark R, Hammond SA, Cremer I, Damotte D, Fridman WH, Sautès-Fridman C, Dieu-Nosjean MC, Cancer Res 2014 74 3 705 715
21. Characteristics of tertiary lymphoid structures in primary cancers. Goc J, Fridman WH, Sautes-Fridman C, Dieu-Nosjean MC, Oncoimmunol 2013 2 12 26836
22. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Germain C, Gnjatic S, Tamzalit F, Knockaert S, Remark R, Goc J, Lepelley A, Becht E, Katsahian S, Bizouard G, Validire P, Damotte D, Alifano M, Magdeleinat P, Cremer I, Teillaud JL, Fridman WH, Sautès-Fridman C, Dieu-Nosjean MC, Am J Respir Crit Care Med 2014 189 7 832 844
23. Tertiary intratumor lymphoid tissue in colo-rectal cancer. Bergomas F, Grizzi F, Doni A, Pesce S, Laghi L, Allavena P, Mantovani A, Marchesi F, Cancers 2011 4 1 1 10
24. REporting recommendations for tumour MARKer prognostic studies (REMARK). McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM, Br J Cancer 2005 93 4 387 391
25. Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts. Hadler-Olsen E, Wetting HL, Rikardsen O, Steigen SE, Kanapathippillai P, Grénman R, Winberg J-O, Svineng G, Uhlin-Hansen L, Virchows Arch 2010 457 6 677 692
26. The immune microenvironment of human tumors: general significance and clinical impact. Fridman WH, Dieu-Nosjean MC, Pages F, Cremer I, Damotte D, Sautes-Fridman C, Galon J, Cancer Microenvironment 2013 6 2 117 122
27. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. Page G, Lebecque S, Miossec P, J Immunol 2002 168 10 5333 5341
28. Tertiary lymphoid organs in infection and autoimmunity. Neyt K, Perros F, van Geurts Kessel CH, Hammad H, Lambrecht BN, Trends Immunol 2012 33 6 297 305
29. Overexpression of transforming growth factor β1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Lu S-L, Reh D, Li AG, Woods J, Corless CL, Kulesz-Martin M, Wang X-J, Cancer Res 2004 64 13 4405 4410
30. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML, J Clin Oncol 2013 31 36 4550 4559
31. Cancer stem cells-new and potentially important targets for the therapy of oral squamous cell carcinoma. Costea D, Tsinkalovsky O, Vintermyr O, Johannessen A, Mackenzie I, Oral Dis 2006 12 5 443 454
32. Antitumor immunity and cancer stem cells. Schatton T, Frank MH, Ann N Y Acad Sci 2009 1176 1 154 169